Literature DB >> 8329725

Lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients.

E Manzato1, A Zambon, S Zambon, R Nosadini, A Doria, R Marin, G Crepaldi.   

Abstract

Patients with type 1 (insulin-dependent) diabetes mellitus in good metabolic control usually have normal plasma lipid levels yet they have an increased incidence of vascular complications. Abnormalities in the distribution and composition of lipoprotein subfractions might in part be responsible for the macroangiopathy seen in type 1 diabetes mellitus. The plasma lipids, lipoproteins and apolipoproteins were studied in 9 type 1 diabetic patients during conventional insulin therapy and in 14 healthy controls. Plasma lipoproteins were analysed by ultracentrifugation in a zonal rotor to evaluate their concentrations and flotation properties and for compositional analysis. In diabetic patients the mean glycosylated haemoglobin (HbA1c) was 9.44 +/- 1.02% and the plasma lipid concentrations were not significantly different from healthy controls. The very low density lipoprotein (VLDL) subclass cholesterol concentrations were no different in diabetic patients and control subjects, but the VLDL cholesterol/triglyceride ratio was significantly lower in diabetic patients than in control subjects (0.43 +/- 0.05 vs 0.85 +/- 0.14; p < 0.05). The flotation rate LDL2, the major component of low density lipoprotein (LDL) was lower in the diabetic patients compared with the control subjects. The cholesterol concentrations of intermediate density lipoprotein and LDL3, the minor component of LDL, were significantly higher (0.17 +/- 0.03 and 0.83 +/- 0.14 mmol/l respectively) in diabetic patients than in control subjects (0.05 +/- 0.02 and 0.24 +/- 0.08 mmol/l). The flotation properties and cholesterol concentrations of the high density lipoprotein (HDL) subclass, and the protein-lipid composition of LDL2, HDL2 and HDL3, were no different in diabetic patients and control subjects.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8329725     DOI: 10.1007/bf00572867

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  45 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  Relation of high-density lipoprotein cholesterol concentration to type of diabetes and its control.

Authors:  A L Kennedy; T R Lappin; T D Lavery; D R Hadden; J A Weaver; D A Montgomery
Journal:  Br Med J       Date:  1978-10-28

3.  The effect of improved diabetic control on plasma lipid and lipoprotein levels: a comparison of conventional therapy and continuous subcutaneous insulin infusion.

Authors:  A Pietri; F L Dunn; P Raskin
Journal:  Diabetes       Date:  1980-12       Impact factor: 9.461

4.  A simple method for measuring cholesterol of serum lipoproteins directly in the effluent from a zonal rotor.

Authors:  E Manzato; D Tempesta; G Baggio; R Fellin; G Crepaldi
Journal:  Clin Chim Acta       Date:  1983-06-15       Impact factor: 3.786

5.  Differences in lipoprotein subfraction composition and distribution between type I diabetic men and control subjects.

Authors:  R W James; D Pometta
Journal:  Diabetes       Date:  1990-10       Impact factor: 9.461

6.  Characterization of subfractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normolipemic and hyperlipemic humans.

Authors:  T Sata; R J Havel; A L Jones
Journal:  J Lipid Res       Date:  1972-11       Impact factor: 5.922

7.  Characterization with zonal ultracentrifugation of low-density lipoproteins in type V hyperlipoproteinemia.

Authors:  E Manzato; A Gasparotto; R Marin; G Baggio; G Baldo; G Crepaldi
Journal:  Biochim Biophys Acta       Date:  1984-05-11

8.  Outpatient treatment of juvenile-onset diabetes with a preprogrammed portable subcutaneous insulin infusion system.

Authors:  W V Tamborlane; R S Sherwin; M Genel; P Felig
Journal:  Am J Med       Date:  1980-02       Impact factor: 4.965

9.  Low-density lipoprotein subclass patterns and risk of myocardial infarction.

Authors:  M A Austin; J L Breslow; C H Hennekens; J E Buring; W C Willett; R M Krauss
Journal:  JAMA       Date:  1988-10-07       Impact factor: 56.272

10.  Lipoprotein abnormalities in insulin-dependent diabetes mellitus.

Authors:  P H Winocour; P N Durrington; M Ishola; D C Anderson
Journal:  Lancet       Date:  1986-05-24       Impact factor: 79.321

View more
  3 in total

1.  Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial.

Authors:  J Q Purnell; S M Marcovina; J E Hokanson; H Kennedy; P A Cleary; M W Steffes; J D Brunzell
Journal:  Diabetes       Date:  1995-10       Impact factor: 9.461

2.  Very low density lipoprotein subfraction abnormalities in IDDM patients: any effect of blood glucose control?

Authors:  L Patti; L Di Marino; A Maffettone; G Romano; G Annuzzi; G Riccardi; A A Rivellese
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

3.  Increased Small Dense LDL and Decreased Paraoxonase Enzyme Activity Reveals Formation of an Atherogenic Risk in Streptozotocin-Induced Diabetic Guinea Pigs.

Authors:  Mutay Aslan; Filiz Ozcan; Ertan Kucuksayan
Journal:  J Diabetes Res       Date:  2013-03-27       Impact factor: 4.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.